Try our beta test site
31 studies found for:    Northwestern AND Lupus
Show Display Options
Rank Status Study
1 Not yet recruiting Lupus Intervention for Fatigue Trial
Conditions: Fatigue;   Physical Activity;   Lupus Erythematosus, Systemic
Interventions: Behavioral: Experimental;   Other: Control
2 Completed
Has Results
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Behavioral: Cutaneous Lupus educational script
3 Active, not recruiting Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Hematopoietic stem cell transplantation
4 Withdrawn Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic Stem Cell Transplantation
5 Active, not recruiting Activity and Nutrition Trial in Lupus to Energize and Renew
Conditions: Systemic Lupus Erythematosus;   Physical Activity;   Sleep
Interventions: Other: Smartphone Application;   Other: Fitbit Activity Monitor;   Other: Coaching Sessions
6 Completed Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Immune ablation and hematopoietic stem cell support.
7 Unknown  Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: filgrastim;   Procedure: CD34+ Peripheral Blood Stem Cell Reinfusion
8 Completed Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
9 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
10 Completed Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
11 Completed Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
12 Terminated Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Interventions: Biological: Autologous Stem Cell Transplant;   Biological: Allogeneic Stem Cell Transplant
13 Completed A Trial of Rosuvastatin in Systemic Lupus Erythematosus
Conditions: Atherosclerosis;   Systemic Lupus Erythematosus
Interventions: Drug: Rosuvastatin;   Drug: Placebo
14 Withdrawn Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
Condition: Systemic Lupus Erythematosus
Interventions: Procedure: Leukapheresis;   Procedure: Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT);   Procedure: Autologous CD34+HPC transplantation (HSCT);   Procedure: Plasmapheresis;   Drug: Rabbit anti-thymocyte globulin;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Drug: Corticosteroids;   Drug: Mycophenolate mofetil;   Drug: Azathioprine;   Drug: Intravenous immunoglobulin;   Drug: Methotrexate;   Drug: Rituximab;   Drug: Leflunomide
15 Completed To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Interventions: Drug: CC-11050;   Other: Placebo
16 Completed Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
Conditions: Immunologic Diseases;   Autoimmune Diseases;   Systemic Lupus Erythematosus;   Lupus Nephritis;   Lupus Glomerulonephritis
Intervention: Drug: Abetimus sodium (LJP 394)
17 Completed
Has Results
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Placebo;   Drug: Belimumab 1 mg/kg;   Drug: Belimumab 4 mg/kg;   Drug: Belimumab 10 mg/kg
18 Not yet recruiting MsciSLE: MSCs in SLE Trial
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Low Dose Mesenchymal Stem Cells (MSCs);   Drug: High Dose Mesenchymal Stem Cells (MSCs);   Drug: Placebo Infusion
19 Recruiting A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: XmAb5871;   Biological: Placebo to match XmAb5871
20 Recruiting Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Conditions: Systemic Lupus Erythematosus;   Antiphospholipid Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.